Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers
NCT00666991
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Peritoneal Neoplasms
Interventions
DRUG:
nanoparticulate paclitaxel
Sponsor
CritiTech, Inc.
Collaborators
[object Object]
[object Object]